Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235571 · ClinicalTrials.gov registry record · NA
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 470
- Enrollment target
NCT02235571 is a NA study that has completed, run by Emory University. The registered enrollment target is 470 participants.
The verdict
NCT02235571, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 470 participants
- Enrollment target
Study Summary
The investigators developed iChoose Kidney -- a shared decision-making support tool accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers with a simple, standardized, easily accessible, statistically robust tool for use in the clinic to guide patient education and healthcare decision-making about treatment options of dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with estimates of their individualized 1 and 3-year risks of mortality on dialysis vs. transplantation, based on previous national data. The tool has the potential to improve communication and decision-making between patients and their healthcare providers and improve access to kidney transplantation among patients with ESRD. This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers with diverse patient populations. One group of patients will receive standard education alone during their scheduled transplant evaluation. The second group will receive the standard education as well have the provider use the iChoose Kidney aid with them. The project timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and outcome evaluation. This study will assess how well the iChoose decision aid works in improving patient knowledge, preferences for treatment, and patient access to transplant. The study will also assess whether providers find the tool useful for providing ways to share information with patients about ways to treat their kidney disease.
Interventions
- BEHAVIORAL iChoose Kidney Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235571
The ClinicalTrials.gov registry entry for NCT02235571 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 470 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iChoose Kidney Decision Aid is the first listed.
NCT02235571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02235571 about?
NCT02235571 is a clinical study titled "iChoose Decision Kidney Aid for End-Stage Renal Disease Patients". The investigators developed iChoose Kidney -- a shared decision-making support tool accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers with a simple, standardized, easily accessible, statistically robust tool for use in the clinic to guide patient education a...
What is the current status of trial NCT02235571?
This trial is currently completed. It is a NA study. The enrollment target is 470 participants. The study started on 2014-09. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02235571?
The interventions under investigation include: iChoose Kidney Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT02235571?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.